EMulate Therapeutics Announces the Publication of Positive Pre-clinical Data Evaluating Pain Reduction via Delivery of Low and Ultra-low Radio Frequency Energy

Written By Kyle Kingma
Kyle Kingma
Previous

Magnetic field tech captures the ‘song’ of a drug
Next

EMulate Therapeutics Announces the Incorporation of A New Wholly Owned Subsidiary